Rachel Njeim

Beirut, BA, Lebanon

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Growth Differentiation Factor-15 in Diabetic Kidney and Cardiovascular Disease: Pathogenic Driver or Protective Modulator.

Growth Differentiation Factor-15 in Diabetic Kidney and Cardiovascular Disease: Pathogenic Driver or Protective Modulator.

Journal: Diabetes
Published: February 06, 2026

Mesenchymal Stem Cell and Secretome Treatments Inhibit the mTOR-NOX4 Pathway in Diabetic Kidney Disease.

Mesenchymal Stem Cell and Secretome Treatments Inhibit the mTOR-NOX4 Pathway in Diabetic Kidney Disease.

Journal: Diabetes
Published: November 14, 2025

Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.

Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.

Journal: Pharmaceutics
Published: August 28, 2023

SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism.

SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism.

Journal: Pharmaceutics
Published: January 04, 2023

VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease.

VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease.

Journal: Diabetes
Published: July 20, 2022

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.

Journal: The Journal of clinical investigation
Published: April 18, 2022

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

Journal: Journal of advanced research
Published: August 12, 2021

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.

Journal: Biomedicines
Published: July 13, 2021

COVID-19 and diabetes mellitus: how one pandemic worsens the other.

COVID-19 and diabetes mellitus: how one pandemic worsens the other.

Journal: Reviews in endocrine & metabolic disorders
Published: August 04, 2020

NETosis contributes to the pathogenesis of diabetes and its complications.

NETosis contributes to the pathogenesis of diabetes and its complications.

Journal: Journal of molecular endocrinology
Published: July 30, 2020

Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury.

Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury.

Journal: Clinical science (London, England : 1979)
Published: December 16, 2019

Novel triazine-based pyrimidines suppress glomerular mesangial cells proliferation and matrix protein accumulation through a ROS-dependent mechanism in the diabetic milieu.

Novel triazine-based pyrimidines suppress glomerular mesangial cells proliferation and matrix protein accumulation through a ROS-dependent mechanism in the diabetic milieu.

Journal: Bioorganic & medicinal chemistry letters
Published: February 27, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026